Bulevirtide (Myrcludex B) acetate

TargetMol
Product Code: TAR-T35373L
Supplier: TargetMol
CodeSizePrice
TAR-T35373L-1mg1mg£229.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35373L-5mg5mg£407.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35373L-10mg10mg£570.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35373L-25mg25mg£867.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35373L-50mg50mg£1,139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35373L-100mg100mg£1,500.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Bulevirtide (Myrcludex B) acetate is a virion entry inhibitor which blocks the virion's hepatocyte pathway of entry, the hepatic sodium/taurocholate cotransporting polypeptide (NTCP) receptor. Bulevirtide (Myrcludex B) acetate can be used in HBV and HDV infection studies.
CAS:
0
Formula:
0
Molecular Weight:
0
Pathway:
Microbiology/Virology
Purity:
0.98
SMILES:
0
Target:
HBV

References

Yardeni D, Koh C. Bulevirtide for HBV and HDV infections. Drugs Today (Barc). 2021 Jul;57(7):433-448.